Humana Inc. (0J6Z.L) • LSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold 0J6Z.L in your mock portfolio yet.
Humana’s valuation and earnings profile look fundamentally attractive despite recent stock price weakness. A low PE ratio of 8.08 combined with solid EPS of 23.55 suggests the market is heavily discounting the business relative to its current earnings power, implying either cyclical or sentiment-driven pressure rather than a collapse in fundamentals. On a standalone basis, profitability metrics point to a company that remains solidly profitable and potentially undervalued if earnings prove sustainable.
Price action and technicals are clearly negative in the near term. The stock is down 29.1% in the last month and trading dramatically below its 200-day moving average of $457.66, signaling a strong downtrend and significant loss of investor confidence. RSI at 36.84 shows the stock is approaching oversold territory, which may limit downside in the very short term but does not yet confirm a reversal.
Alternative data for Humana is mixed: operational and customer-engagement signals remain large in absolute terms but show some softening at the margin. Web traffic and app downloads are high, indicating strong ongoing user engagement, but the 6.7% month-over-month decline in app downloads and a 24.5% drop in job openings suggest a more cautious growth or hiring stance. Social media followership is sizable and broadly stable, with modest growth on some platforms and flat on others, pointing to a steady but not rapidly expanding brand presence.
Humana’s fundamentals and valuation appear stronger than the current stock price implies, but the technical picture and some softening in alternative data justify caution. The combination of a very low PE and solid EPS with severe recent price declines suggests a disconnect that could represent value if earnings remain resilient, yet the market is clearly pricing in elevated risk or structural concerns. Overall, the setup is balanced between potential upside from mean reversion and the possibility that negative sentiment and operational caution persist.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started